Initial safety and efficacy of cisplatin and gemcitabine combination chemotherapy for unresectable biliary tract cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 41, Issue 13, 2014, Pages 2599-2602

  Shibata, Yoshihiro ^a  

^a KOUSEIREN TAKAOKA HOSPITAL   (Japan)

Author keywords

Advanced biliary tract cancer; Cisplatin and gemcitabine; Efficacy; Safety profile

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ANOREXIA; ARTICLE; BILE DUCT CANCER; BILIARY TRACT CANCER; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED ANEMIA; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ELECTRONIC MEDICAL RECORD; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HUMAN; INOPERABLE CANCER; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MIDDLE AGED; MONOTHERAPY; NEUROPATHY; NEUROTOXICITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PATIENT HISTORY OF CHEMOTHERAPY; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; VATER PAPILLA;

EID: 84924855321     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Matsuda T and Marugame T: International comparisons of cumulative risk of gallbladder cancer and other biliary tract cancer, from Cancer Incidence in Five Continents Vol. VIII. Jpn J Clin Oncol 37(1):74-75, 2007.
2. Randi G, Malvezzi M, Levi F, et al: Epidemiology of biliary tract cancers: an update. Ann Oncol 20(1):146-159, 2009.
3. Pichlmayr R, Lamesch P, Weimann A, et al: Surgical treatment of cholangiocellular carcinoma. World J Surg 19(1):83-88, 1995.
4. Valverde A, Bonhomme N, Farges O, et al: Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 6(2):122-127, 1999.
5. Valle J, Wasan H, Palmer DH, et al: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273-1281, 2010.
6. Okusaka T, Nakachi K, Fukutomi A, et al: Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103(4):469-474, 2010.
7. Thongprasert S, Napapan S, Charoentum C, et al: Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16(2):279-281, 2005.
8. Kim ST, Park JO, Lee J, et al: A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106(6):1339-1346, 2006.
9. Charoentum C, Thongprasert S, Chewaskulyong B, et al: Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol 13(20):2852-2854, 2007.
10. Meyerhardt JA, Zhu AX, Stuart K, et al: Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci 53(2):564-570, 2008.
11. Valle JW, Wasan H, Johnson P, et al: Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study-The UK ABC-01 Study. Br J Cancer 101(4):621-627, 2009.